0001415889-21-006124.txt : 20211220 0001415889-21-006124.hdr.sgml : 20211220 20211220162314 ACCESSION NUMBER: 0001415889-21-006124 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211217 FILED AS OF DATE: 20211220 DATE AS OF CHANGE: 20211220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHABER CHRISTOPHER J CENTRAL INDEX KEY: 0001068029 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 211505551 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER NAME: FORMER CONFORMED NAME: SCHABER CHRISTOPHER DATE OF NAME CHANGE: 19980811 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 4 1 form4-12202021_011204.xml X0306 4 2021-12-17 0000812796 SOLIGENIX, INC. SNGX 0001068029 SCHABER CHRISTOPHER J C/O SOLIGENIX, INC. 29 EMMONS DRIVE, SUITE B-10 PRINCETON NJ 08540 true true false false CHAIRMAN, CEO AND PRESIDENT COMMON STOCK 2021-12-17 4 P 0 7000 0.7399 A 70095 D This transaction was executed in multiple trades at prices ranging from $0.7399 to $0.74. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. /s/ Christopher J. Schaber 2021-12-20